Professional Documents
Culture Documents
PERIAMPULLARY TUMORS
AND THE DISSECTION OF THE
WHIPPLE RESECTION
IN
MEMORIAM
ALLEN O.
WHIPPLE,
M.D.
1881 - 1963
WHIPPLE PROCEDURE
PERFORMED FOR
Periampullary Tumors (104)
Pancreatic CA -70
Ampullary CA -20
Duodenal CA -10
Distal bile duct CA -4
WHIPPLE PROCEDURE
(PANCREATICODUODENECTOMY)
Specimen
Distal stomach
Duodenum
Head of pancreas
Distal bile duct
Gallbladder
Proximal jejunum
WHIPPLE PROCEDURE
Reconstruction
Pancreatico jejunostomy
Choledocho jejunostomy
Gastrojejunostomy -
WHIPPLE SPECIMEN
Frozen Section
Pancreatic resection
margin
Bile duct margins
WHIPPLE SPECIMEN
Dissect The Unfixed
Specimen
Open the stomach along
greater curvature
Open the duodenum along the
border opposite the pancreas
- Duodenal mucosa looks
dusky because the blood
supply is ligated earlier
in the operation
WHIPPLE SPECIMEN
WHIPPLE SPECIMEN
PANCREATIC CA
Pathologic Features
Gross
Effacement of lobules
Invasive CA
Fibrosis
WHIPPLE SPECIMEN
Periampullary
Tumors
Pancreatic tumors
Bile duct tumors
Ampullary tumors
Duodenal tumors
WHIPPLE SPECIMEN
Record Dimensions
Stomach
Duodenum
Pancreatic head
Margins
Lymph nodes (10)
WHIPPLE SPECIMEN
PANCREATIC CA
Describe The Tumor
Size
Color
Consistency
Cysts
Relationship to anatomic
sites
Distance from margins
Obstruction of ducts
Remainder of pancreatic
parenchyma
WHIPPLE SPECIMEN
Sections (20)
Resection Margins
- Pancreatic
- Uncinate process
- Gastric
- Duodenal
- Common bile duct
Tumor
- Tumor and common bile
- Tumor and pancreatic duct
- Tumor and pancreatic parenchyma
Uninvolved pancreas
Ampulla
Lymph nodes (10)
- Common bile duct
- Pergastric
- Periduodenal
- Pancreatic
ENDOSCOPY
DUODENAL CA
Endoscopic Appearance
3 cm polypoid,
ulcerating CA
WHIPPLE SPECIMEN
DUODENAL CA
Pathologic Features
Gross
3 cm polypoid,
ulcerating CA
WHIPPLE SPECIMEN
DUODENAL CA
Pathologic Features
Micro
Ulcerating Adeno CA
Invades pancreas
Prognosis
5 year survival rate
30%
ENDOSCOPY
AMPULLARY CA - EARLY
Endoscopic Appearance
1.5 polypoid CA
WHIPPLE SPECIMEN
AMPULLARY CA - EARLY
Pathologic Features
Gross
1.5 cm mass
Prognosis
5 year survival rate good
Micro
Invasive adeno CA
Tumor invades pancreas
Prognosis
5 year survival rate 34%
WHIPPLE PROCEDURE
BILE DUCT CA
Pathologic Features
Gross
Protuberant
ampulla
WHIPPLE PROCEDURE
BILE DUCT CA
Pathologic Features
Gross
Mass in distal bile
duct
3 cm papillary CA
Micro
Invasive papillary CA
Metastasis to lymph
node
Prognosis
5 year survival rate
15%
PANCREAS
Anatomy
Head
Body
Tail
PANCREAS
Histology
Exocrine
Acinar cells
Ducts
Endocrine
Islet cells
Insulin
Glucagon
Somatostatin
Pancreatic
polypeptide
PANCREATITIS
Acute
Inflammation
Edema
Fat Necrosis
Hemorrhage
Chronic
Inflammation
Destruction of
exocrine glands
Destruction of
endocrine glands
Fibrosis
CHRONIC PANCREATITIS
Causes
Alcohol abuse
Obstruction
Cystic fibrosis
Hereditary
Tropical
CHRONIC PANCREATITIS
Pathologic Features
Gross
Fibrosis
Dilated ducts
Calcified concretions
CHRONIC PANCREATITIS
Pathologic Features
Micro
Fibrosis
Atrophy of acini
Dilated ducts with
concretions
COMPLICATIONS OF
CHRONIC PANCREATITIS
Pseudocysts
Duct obstruction
Malabsorption
Steatorrhea
Secondary diabetes
Carcinoma
Solid Neoplasms
Pancreatic ductal
adenocarcinoma
Endocrine tumors
PANCREATIC CARCINOMA
Clinical Features
Fourth leading cause of
cancer death in U.S.
30,000 patients diagnosed
and die from it
Genetic disease:
mutations in K-RAS, p53
PANCREATIC DUCTAL
ADENOCARCINOMAS
Diagnosis
ERCP (endoscopic
retrograde cholangiopancreatography)
Fine needle aspiration
biopsy
Ct scan
CA-19-9
PANCREATIC DUCTAL
CARCINOMAS
Risk Factors
Tobacco abuse
Chronic pancreatitis
Hereditary pancreatitis
Diet (high in fats and
meats)
Chemical carcinogen
exposure
Pancreatic Intraepithelial
Neoplasias (PanINs)
Pan INs 1
CA
PANCREATIC CARCINOMA
PATHOLOGY
Microscopic
Poorly formed
glands in fibrotic
stroma
METASTATIC PANCREATIC CA
TO LIVER
Hematogenous
Metastases
Portal vein
Hepatic artery
WHIPPLE PROCEDURE
Complications
WHIPPLE PROCEDURE
Cost
$34,000 to $92,000
High-volume centers
- Lower hospital cost
- Shorter hospital stay
- Lower morbidity
PARK